海外の治験の状況「前立腺癌」での検索結果
648件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
- Stage II Prostate Adenocarcinoma AJCC v7
- Singapore, United States
- 2016-03-11
Recruiting
- SHORT Course Radiotherapy for Localized Prostate Cancer
- Prostate Cancer
- India
- 2016-02-22
Recruiting
- A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
- Hormone Refractory Prostate Cancer;Metastatic Prostate Carcinoma;Hormone Refractory Prostate Cancer;Metastatic Prostate Carcinoma;Hormone Refractory Prostate Cancer;Metastatic Prostate Carcinoma;Hormone Refractory Prostate Cancer;Metastatic Prostate Carcinoma
- China
- 2016-02-17
Not recruiting
- An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
- Prostatic Neoplasms
- Argentina, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Czechia, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2015-08-21
Recruiting
- Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
- Latent Cancer Prostate
- Taiwan
- 2017-06-29
Recruiting
- 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- China
- 2017-05-23
Recruiting
- Establishment of Prostate Cancer Database and Its Clinical Application
- Prostate Cancer
- China
- 2017-04-22
Not Recruiting
- Educational program about screening and prevention of prostate cancer
- Prostate Cancer. br>Malignant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate, ant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate;C61, D07.5;Malignant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate, ant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate
- Iran (Islamic Republic of)
- 2017-04-18
Not recruiting
- Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);Metastatic Castration-Resistant Prostate Cancer (mCRPC);Metastatic Castration-Resistant Prostate Cancer (mCRPC);Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Russian Federation
- 2017-03-03
Authorised
- A study to evaluate Rucaparib versus physician’s choice of therapy in patients with metastatic castration-resistant prostate cancer
- Metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Spain, United Kingdom, United States
- 2017-02-16